Abstract:Esophageal carcinoma (EC) is one of the most common digestive tract malignancies, and is the sixth most common cause of cancer death worldwide1,2. EC has the two major histological types, including squamous cell carcinoma and adenocarcinoma3. Especially in China, esophageal squamous cell carcinoma (ESCC) is the major histological type4. Although significant improvement has been achieved in surgical techniques and adjuvant treatment, the clinical prognosis of ESCC remains very poor due to early lymph node metastasis and invasion of neighboring organs5. Recent years, many research focused on the pathogenesis of ESCC. However, the underlying mechanisms of the tumorigenesis and metastasis of ESCC remain largely unclear. Deeper investigation of the molecular mechanism on progression of ESCC was important to explore new biomarkers for the prognosis and treatment of ESCC. MicroRNA (miRNA) is a novel class of short, endogenous, non-coding RNA with 18-25 nucleotides in length6. Mature miRNAs negatively regulate their target genes through imperfect comAbstract. – OBJECTIVE: The aim of the current study was to elucidate the role of miR-4553p in the pathogenesis of esophageal squamous cell carcinoma (ESCC) and its prognostic value in patients with ESCC. PATIENTS AND METHODS: Expression levels of miR-455-3p and FAM83F mRNA in ESCC tissues and adjacent normal tissues were detected by quantitative RT-PCR. The X2-test was used to assess miR-455-3p expression on clinicopathological parameters. The association with overall survival of patients was analyzed by Kaplan-Meier survival analysis. Cox’s multivariate regression model was performed to identify independent prognostic factors of overall survival. The effect of miR-455-3p on proliferation was evaluated by kit-8 (CCK-8), and cell invasion was evaluated by transwell assays. The molecular target of miR-455-3p was identified using a computer algorithm and confirmed experimentally. Furthermore, the effect of miR-455-3p up-regulation on FAM83F expression was examined by Western blot. RESULTS: miRNA-455-3p was significantly increased in ESCC tissues and cell lines. Also, miR-455-3p expression was significantly associated with histological grade, lymph nodes metastasis and clinical stage (all p < 0.05). The patients with low miR-455-3p expression had shorter survival time than those with high miR455-3p expression. Furthermore, univariate and multivariate analysis identified low miR-455-3p expression as an unfavorable prognostic factor for overall survival. Moreover, transfection with the miR-455-3p mimic enhanced the cell proliferation and invasion in ESCC cells. Luciferase reporter assays confirmed that miR-455-3p binding to the 3’-UTR regions of FAM83F inhibited the expression of FAM83F in ESCC cells. Western blot confirmed that overexpression of miR455-3p resulted in down-regulation of FAM83F in ESCC cells. European Review for Medical and Pharmacological Sciences 2017; 21: 3200-3206

MiR‐372‐3p Promotes Cell Growth and Metastasis by Targeting FGF9 in Lung Squamous Cell Carcinoma

MicroRNA-9 Regulates Non-Small Cell Lung Cancer Cell Invasion and Migration by Targeting Eukaryotic Translation Initiation Factor 5A2.

MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.

miRNA-9 Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Regulating NRSF/EGFR.

Investigation of Targeting Relationship Between Micro-Rna-22 and Vegfr3 in Lung Squamous Cell Carcinoma

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2)

MiR-5189-3p Suppresses cell Proliferation, Invasion and Migration Through Targeting EIF5A2 in Laryngeal Squamous Cell Carcinoma

Downregulation of miR-499a-5p Predicts a Poor Prognosis of Patients With Non-Small Cell Lung Cancer and Restrains the Tumorigenesis by Targeting Fibroblast Growth Factor 9

Mir-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma

MiR-455-3 p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM 83 F

Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression

MiR-143-3p Suppresses Cell Proliferation, Migration, and Invasion by Targeting Melanoma-Associated Antigen A9 in Laryngeal Squamous Cell Carcinoma

miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3

Mir-187 Inhibits the Growth of Cervical Cancer Cells by Targeting FGF9

Lung CSC‐derived Exosomal Mir‐210‐3p Contributes to a Pro‐metastatic Phenotype in Lung Cancer by Targeting FGFRL1

MiR-875-5p Suppresses Cervical Cancer Cell Proliferation and Metastasis Via Negative Regulation of EGFR

FGF9/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer

Mir-367 Promotes the Proliferation and Invasion of Non-Small Cell Lung Cancer Via Targeting FBXW7.

Tumor-Suppressive Function of Mir-139-5p in Esophageal Squamous Cell Carcinoma

Dysregulated <i>LINC00961</i> Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p

MicroRNA‑433 Reduces Cell Proliferation and Invasion in Non‑small Cell Lung Cancer Via Directly Targeting E2F Transcription Factor 3.